CV Therapeutics ( CVTX) said late Thursday that it had a narrower fourth-quarter loss than expected, while revenue jumped past targets. The stock was recently adding 76 cents, or 6.1%, to $13.15.

Monogram Biosciences ( MGRM) was higher after reporting a fourth-quarter loss that narrowed from a year ago and was in line with expectations. Monogram was adding 7 cents, or 4%, to $1.83.

Cell Therapeutics ( CTIC) was trading lower a day after the company announced it will sell $17.6 million of convertible preferred stock and warrants. Cell Therapeutics was losing 6 cents, or 3.7%, to $1.57.

Among health care stocks gaining ground, Cell Genesys ( CEGE) was surging 7.9% to $3.57. MedImmune ( MEDI) was adding 1.5% to $31.87. GlaxoSmithKline ( GSK) was tacking on 1.4% to $56.62.

Among decliners, Amylin Pharmaceuticals ( AMLN) fell 2.1% to $40.79. Gilead Sciences ( GILD) was off 1.6% to $70.98. Forest Laboratories ( FRX) was slipping 1.5% to $54.53.

If you liked this article you might like

Paradigm Opportunity Protects Investors in Tough Times

Paradigm Opportunity Protects Investors in Tough Times

5 Things You Need to Know Before the Stock Market Opens (Correct)

5 Things You Need to Know Before the Stock Market Opens (Correct)

U.S. Investors Brace for a Third Bailout in Greece

U.S. Investors Brace for a Third Bailout in Greece

5 Things You Need to Know Before the Stock Market Opens

5 Things You Need to Know Before the Stock Market Opens

40 Hedge Funds' Best Stocks Show the Way for 2012 (Update 1)

40 Hedge Funds' Best Stocks Show the Way for 2012 (Update 1)